Terascala, the fast data company, has announced that Jamie Coffin, former vice president and general manager for Dell Healthcare and Life Science division, has joined Terascala’s Board of Directors.
The appointment of Coffin is a direct result of Terascala’s momentum in life sciences, specifically in the genome analysis industry. Coffin’s background is as a computational chemist, followed by executive leadership positions in life sciences at IBM and Dell.
According to Coffin, the life sciences industry, especially next generation sequencing (NGS), is embracing HPC at an increasingly fast pace: ‘While the ability to sequence genetic data has made dramatic leaps over the past several years, the ability to collect, store, and analyse that data is a growing challenge. For many organizations, NGS is an exciting possibility, yet it is still beyond the reach of their budgets and capabilities. With Terascala, that’s no longer the case.’
Terascala allows organisations to combine larger compute clusters and turnkey, multi-tier storage with a high performance data mover to manage the data across the infrastructure.
‘Terascala's TeraOS and Intelligent Storage Bridge high-performance data movement solution have made the two tier storage architecture a reality, delivering real advantages in cost, flexibility, and performance over monolithic storage approaches common in today’s sequencing organisations. Further, Terascala’s technology makes it incredibly easy for organisations of all sizes to deploy HPC because it enables fast, simple, and easy to use appliances. That's the recipe the life sciences industry has always desired, and I am excited to be a part of it,’ concluded Coffin.
